1. Crystal Structure of the Apicoplast DNA Polymerase from Plasmodium falciparum: The First Look at a Plastidic A-Family DNA Polymerase
- Author
-
Richard B. Honzatko, Jun-Yong Choe, Scott W. Nelson, and Morgan E. Milton
- Subjects
Models, Molecular ,0301 basic medicine ,Genetics ,Exonuclease ,Apicoplast ,DNA clamp ,biology ,Protein Conformation ,DNA polymerase ,DNA polymerase II ,Plasmodium falciparum ,DNA-Directed DNA Polymerase ,DNA Exonuclease ,Apicoplasts ,Crystallography, X-Ray ,biology.organism_classification ,03 medical and health sciences ,030104 developmental biology ,Protein Domains ,Structural Biology ,parasitic diseases ,biology.protein ,Molecular Biology ,Polymerase - Abstract
Plasmodium falciparum , the primary cause of malaria, contains a non-photosynthetic plastid called the apicoplast. The apicoplast exists in most members of the phylum Apicomplexa and has its own genome along with organelle-specific enzymes for its replication. The only DNA polymerase found in the apicoplast (apPOL) was putatively acquired through horizontal gene transfer from a bacteriophage and is classified as an atypical A-family polymerase. Here, we present its crystal structure at a resolution of 2.9 A. P. falciparum apPOL, the first structural representative of a plastidic A-family polymerase, diverges from typical A-family members in two of three previously identified signature motifs and in a region not implicated by sequence. Moreover, apPOL has an additional N-terminal subdomain, the absence of which severely diminishes its 3ʹ to 5ʹ exonuclease activity. A compound known to be toxic to Plasmodium is a potent inhibitor of apPOL, suggesting that apPOL is a viable drug target. The structure provides new insights into the structural diversity of A-family polymerases and may facilitate structurally guided antimalarial drug design.
- Published
- 2016